Philippe Ruszniewski

Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text

Medicine, Oncology, Pharmacology +17

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine · 2011 · 2.5K citations

Medicine, Oncology, Pharmacology +11

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text

Medicine, Endocrinology, Oncology +17

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

James C. Yao, Catherine Lombard‐Bohas, Éric Baudin et al. · Journal of Clinical Oncology · 2009 · 649 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

F. Huguet, Thierry André, Pascal Hammel et al. · Journal of Clinical Oncology · 2007 · 536 citations · Full text

Medicine, Oncology, Radiation Oncology +16